About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Fecal Microbiota Transplantation for Ulcerative Colitis

NCT01742754·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Washington

With

The Broad Foundation

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Mild to moderate UC.

You may not be if

Antibiotic exposure in the last 3 months.
Biologic or immunomodulatory therapy within the last 3 months.
Corticosteroid therapy or probiotics within the last 2 weeks.
Severely active disease (defined as Mayo scores of 10 or greater, or patients with endoscopic disease activity scores of 3 or greater).

The record

StatusTerminated

PhaseNo phase

Taking part7

StartedOct 2012

UpdatedNov 13, 2013

Conditions

Ulcerative Colitis

Where1

University of Washington
Seattle, Washington, United States

Clareo Health | Fecal Microbiota Transplantation for Ulcerative Colitis